Evidence map›Paper›PMID 31402862›Full record

ArticleFrontiers in pharmacology2019

An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation

Xiaoming Wang, Xiaoyan Chang, Xiaomei Luo, Meifeng Su, Rong Xu, Jun Chen, Yi Ding, Yue Shi

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. DietaryAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Stress-Induced Secondary Metabolite Profiling inInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Polyphenols and Other Bioactive Compounds ofMolecules (Basel, Switzerland) · 2020
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoming WangInstitute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Xiaoyan ChangInstitute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Xiaomei LuoInstitute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Meifeng SuBeijing University of Chinese Medicine, Beijing, China.
Rong XuInstitute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Jun ChenInstitute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Yi DingSchool of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Yue ShiInstitute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal bacteria have a significant role in metabolism and the pharmacologic actions of traditional Chinese medicine active ingredients. Phenylethanoid glycosides (PhGs), as typical phenolic natural products, possess wide bioactivities, but low oral bioavailability. The aim of this work was to elucidate the metabolic mechanism underlying PhGs in the intestinal tract and screen for more active metabolites. In this study, a rapid and reliable method using an effective post-acquisition approach based on advanced ultra-high-performance liquid chromatography (UHPLC) coupled with hybrid Quadrupole-Orbitrap high resolution mass spectrometry (Q-Exactive-HRMS) provided full MS and HCD MS

Indexed as

antioxidant activitiesfour phenylethanoid glycosidesintestinal microbial metabolismstructure–activity relationshipUHPLC-Q-Exactive Orbitrap HRMS

Identifiers

PMID31402862
PMCPMC6669795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.